De Bacci Capital Hosts Fundraising Reception for Ocutrx Technologies in Dubai

De Bacci Capital hosted an exclusive fundraising reception for Ocutrx Technologies, a US-based company, led by the Emmy-Award-winning Founder, in Dubai.

Michael Freeman and Simon Prosser from Ocutrx Technologies, presented a limited investment opportunity in their unique technology that combines AR, 3D and medical innovation.

Taken place at the prominent business center in Dubai Downtown, next to the Burj Khalifa, the event was attended by a vetted group of angel investors, venture capitalists, private equity firms, investment bankers, family offices, and advisors from De Bacci Capital’s network. Among the attendees were Al Beed Investment Group, Dubai Investments Center, Verchool Holdings, CiTech Capital, Pegasus Capital, GRIP Investments, The Beryl Consulting Group, iCapital Ventures, OPUS, The VAST Initiative, Dubai Media Inc., and others.

The following week, the Ocutrx Founders attended a series of one-on-one investor meetings in Dubai and Adu Dhabi.

Key reasons to become a shareholder in OCUTRX:

Ocutrx is a cutting-edge technology company delivering augmented reality (AR) solutions and 3D visualization. Their unique products are designed to enhance surgical precision, improve patient outcomes, and set new benchmarks in the medical industry. 

Ocutrx’s exclusive headsets are redefining the quality of life for patients and the standard of care for surgeons. The Emmy-Award-winning Founders, the robust patent portfolio, and the superior technology specifications position Ocutrx as a leader in this burgeoning space.  

Closing in Q1, this Round offers investors a final chance to join the cap table before product commercialization, when capital needs will dramatically decrease. The next 12-24 months are pivotal as the company launches key products, continues to grow the manufacturing division, and watches revenue skyrocket. Ocutrx welcomes you to take part in their growth.

Current Stage: Series C.

Projected ROI: 2-6X within 3-4 years.

Investment Offering: 18% of the company in exchange for the $50m in investment.

Minimum Ticket Size: $2m.

Pitch deck is available upon request.

For inquiries, please email us: admin@debacciofficial.org

Join our dealflow platform and become part of a legacy that is shaping the future of global business: https://www.dfx-dbc.com

Disclaimer: The content of this website is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. Readers should carefully consider whether investing in the given product is appropriate for them based on their financial circumstances, consider the risks, and seek independent consultation.


Discover more from De Bacci Official

Subscribe to get the latest posts sent to your email.

Leave a comment